The hemodialysis and peritoneal dialysis market is embarking on a transformative journey, with projections indicating substantial growth well into 2034 and beyond. In 2024, the adoption of these life-sustaining therapies is estimated to reach USD 104.3 billion. By 2034, the market is expected to exceed a staggering valuation of USD 245 billion, driven by a robust Compound Annual Growth Rate (CAGR) of 8.9%.
This remarkable growth underscores the increasing demand for dialysis treatments, particularly in regions with high prevalence rates of diabetes and hypertension. As these chronic conditions continue to rise globally, healthcare systems are increasingly turning to hemodialysis and peritoneal dialysis to meet the burgeoning need for effective renal care.
Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14681
Key Highlights:
- Strong Regulatory Framework and Healthcare Infrastructure: North America’s hemodialysis and peritoneal dialysis market is benefiting from the region’s stringent regulatory standards and advanced healthcare infrastructure. Regulatory compliance ensures patient safety and quality of care, while state-of-the-art facilities and technologies facilitate the delivery of effective dialysis treatments.
- Rising Prevalence of Renal Diseases: The increasing prevalence of renal diseases, including chronic kidney disease (CKD) and end-stage renal disease (ESRD), is driving the demand for hemodialysis and peritoneal dialysis treatments. Factors such as aging populations, lifestyle-related risk factors, and improved diagnostic capabilities contribute to the growing burden of renal conditions, necessitating expanded dialysis services.
- Technological Advancements and Innovation: Technological advancements in hemodialysis and peritoneal dialysis modalities are enhancing treatment efficacy, patient comfort, and convenience. Innovations such as wearable dialysis devices, home-based dialysis solutions, and remote monitoring systems are reshaping the dialysis landscape, empowering patients to manage their condition more effectively and improve their quality of life.
- Focus on Personalized and Value-Based Care: The shift towards personalized and value-based care models is driving the adoption of tailored dialysis regimens that optimize patient outcomes and resource utilization. Integrated care approaches, multidisciplinary care teams, and patient-centered initiatives aim to address the holistic needs of individuals with renal diseases, promoting better health outcomes and cost-effective care delivery.
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-14681
Key Takeaways :
- In the type sector, Hemodialys from the Hemodialys and peritoneal dialysis market are anticipated to flourish at the quickest CAGR of 5.5% through 2032.
- With a CAGR of 5.7% through 2032, Hospital Dialysis are predicted to grow significantly in the application sector of the Hemodialys and peritoneal dialysis market.
- The market size for Hemodialys and peritoneal dialysis market in the United States is expected to reach US$ 49.4 Billion by 2032, growing at a CAGR of 6% during the research period.
- China is anticipated to reach a market size of US$ 10.2 billion in Hemodialys and peritoneal dialysis by 2032, with a CAGR of 5.5% during the forecast period.
- By 2032, South Korea is expected to reach a market size of US$ 5.3 Billion in Hemodialys and peritoneal dialysis, with a CAGR of 49% during the forecast period.
COMPETITIVE LANDSCAPE:
The major players in the global hemodialys and peritoneal dialysis market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Cantel Medical Corporation (US), Diaver (US).
RECENT DEVELOPMENT:
- Mar Cor (Cantel Medical Corporation) announced the release of their unique EON Portable Hemodialys Water System in 2021.
- Fresenius Medical Care AG & Co. KGaA announced the release of a PVC-free peritoneal dialysis solution bag for home dialysis therapy in 2020.
- Baxter International Inc. gained FDA clearance for a De Novo application for Theranova dilayzers designed to provide enhanced hemodialys (HDx) treatment in 2020.
KEY SEGMENTS:
By Type:
- Hemodialys
- Peritoneal dialysis
By End Use:
- Hospital Based
By Product:
- Device
- Consumables
- Services
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Gain Full to Market Insights: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/14681
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
